- Home
- RMI
RMI
RiverNorth Opportunistic Municipal Income Fund Inc.
as 03-31-2025 4:00pm EST
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 17.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $13.05 - $17.37 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest RiverNorth Opportunistic Municipal Income Fund Inc. News
RMI Breaking Stock News: Dive into RMI Ticker-Specific Updates for Smart Investing
Business Wire
3 months ago
RiverNorth Closed-End Funds Declare Monthly Distributions
Business Wire
6 months ago
RiverNorth Closed-End Funds Declare Monthly Distributions
Business Wire
9 months ago
RiverNorth Closed-End Funds Declare Monthly Distributions
Yahoo Finance Video
10 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
10 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
10 months ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
10 months ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
GlobeNewswire
10 months ago
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
Compare RMI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RMI RiverNorth Opportunistic Municipal Income Fund Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.